The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global Vaccines market size is expected to reach US$ 66610 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccines in various end use industries. The expanding demands from the Rabies vaccine, Influenza vaccine, HPV vaccine and Hepatitis B, are propelling Vaccines market. Recombinant Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Vaccines segment is estimated at % CAGR for the next seven-year period.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccines covered in this report include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc.
The global Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
Global Vaccines market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccines market, Segment by Type:
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
Global Vaccines market, by Application
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Vaccines Market Overview
1.1 Vaccines Product Overview
1.2 Vaccines Market Segment by Type
1.2.1 Recombinant Vaccines
1.2.2 Viral Vaccines
1.2.3 Polysaccharide Vaccines
1.2.4 Others
1.3 Global Vaccines Market Size by Type
1.3.1 Global Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vaccines Sales Breakdown by Type (2018-2023)
2 Global Vaccines Market Competition by Company
2.1 Global Top Players by Vaccines Sales (2018-2023)
2.2 Global Top Players by Vaccines Revenue (2018-2023)
2.3 Global Top Players by Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccines Market Competitive Situation and Trends
2.5.1 Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Vaccines Market
2.8 Key Manufacturers Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccines Status and Outlook by Region
3.1 Global Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vaccines Historic Market Size by Region
3.2.1 Global Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vaccines Forecasted Market Size by Region
3.3.1 Global Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vaccines by Application
4.1 Vaccines Market Segment by Application
4.1.1 Rabies vaccine
4.1.2 Influenza vaccine
4.1.3 HPV vaccine
4.1.4 Hepatitis B
4.1.5 Hepatitis A
4.1.6 Leprosy vaccine
4.1.7 Polio vaccine
4.1.8 JE vaccine
4.1.9 Others
4.2 Global Vaccines Market Size by Application
4.2.1 Global Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vaccines Sales Breakdown by Application (2018-2023)
5 North America Vaccines by Country
5.1 North America Vaccines Historic Market Size by Country
5.1.1 North America Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Vaccines Sales in Value by Country (2018-2023)
5.2 North America Vaccines Forecasted Market Size by Country
5.2.1 North America Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Vaccines Sales in Value by Country (2024-2029)
6 Europe Vaccines by Country
6.1 Europe Vaccines Historic Market Size by Country
6.1.1 Europe Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Vaccines Forecasted Market Size by Country
6.2.1 Europe Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Vaccines by Region
7.1 Asia-Pacific Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vaccines Sales in Value by Region (2024-2029)
8 Latin America Vaccines by Country
8.1 Latin America Vaccines Historic Market Size by Country
8.1.1 Latin America Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Vaccines Forecasted Market Size by Country
8.2.1 Latin America Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Vaccines by Country
9.1 Middle East and Africa Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Vaccines Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Vaccines Products Offered
10.2.5 Sanofi Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Vaccines Products Offered
10.4.5 Pfizer Recent Development
10.5 Novartis(GSK)
10.5.1 Novartis(GSK) Company Information
10.5.2 Novartis(GSK) Introduction and Business Overview
10.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis(GSK) Vaccines Products Offered
10.5.5 Novartis(GSK) Recent Development
10.6 CSL
10.6.1 CSL Company Information
10.6.2 CSL Introduction and Business Overview
10.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CSL Vaccines Products Offered
10.6.5 CSL Recent Development
10.7 MedImmune LLC
10.7.1 MedImmune LLC Company Information
10.7.2 MedImmune LLC Introduction and Business Overview
10.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 MedImmune LLC Vaccines Products Offered
10.7.5 MedImmune LLC Recent Development
10.8 J&J(Crucell)
10.8.1 J&J(Crucell) Company Information
10.8.2 J&J(Crucell) Introduction and Business Overview
10.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 J&J(Crucell) Vaccines Products Offered
10.8.5 J&J(Crucell) Recent Development
10.9 China National Biotec
10.9.1 China National Biotec Company Information
10.9.2 China National Biotec Introduction and Business Overview
10.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 China National Biotec Vaccines Products Offered
10.9.5 China National Biotec Recent Development
10.10 Tiantan
10.10.1 Tiantan Company Information
10.10.2 Tiantan Introduction and Business Overview
10.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Tiantan Vaccines Products Offered
10.10.5 Tiantan Recent Development
10.11 Hualan
10.11.1 Hualan Company Information
10.11.2 Hualan Introduction and Business Overview
10.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hualan Vaccines Products Offered
10.11.5 Hualan Recent Development
10.12 Kangtai
10.12.1 Kangtai Company Information
10.12.2 Kangtai Introduction and Business Overview
10.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Kangtai Vaccines Products Offered
10.12.5 Kangtai Recent Development
10.13 Hissen
10.13.1 Hissen Company Information
10.13.2 Hissen Introduction and Business Overview
10.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hissen Vaccines Products Offered
10.13.5 Hissen Recent Development
10.14 Jintan
10.14.1 Jintan Company Information
10.14.2 Jintan Introduction and Business Overview
10.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Jintan Vaccines Products Offered
10.14.5 Jintan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccines Industrial Chain Analysis
11.4 Vaccines Market Dynamics
11.4.1 Vaccines Industry Trends
11.4.2 Vaccines Market Drivers
11.4.3 Vaccines Market Challenges
11.4.4 Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccines Distributors
12.3 Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
